Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Rank in Stocks #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Share Price
$1.50
Last synced: 2026-09-21
Market Cap
$3.63M
Change (1 day)
-4.46%
Change (1 year)
-72.68%
Country
MY
Trade BioNexus Gene Lab Corp. (BGLC)

Category

EPS for BioNexus Gene Lab Corp. (BGLC)
EPS as of June 2026 TTM: $-1.26
According to BioNexus Gene Lab Corp. latest financial reports and stock price the company's current EPS (TTM) is $-1.26. At the end of 2023 the company had a EPS of $-1.53 an increase over its 2022 EPS that were of $-0.25.
EPS history for BioNexus Gene Lab Corp. from 2016 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-1.26 40.00%
2024 $-0.90 -41.18%
2023 $-1.53 512.00%
2022 $-0.25 -147.17%
2021 $0.53 -58.59%
2020 $1.28 -3,842.69%
2019 $-0.03 -812.50%
2018 0.00 -124.12%
2017 $-0.02 19,800.00%
2016 0.00 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$39.24 -3,214.29%
US
$1.18 -193.65%
US
- -
US
$14.65 -1,262.70%
US
- -
US